Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar;30(3):402-6.
doi: 10.1002/mds.26084. Epub 2014 Dec 1.

Diagnosing PD-MCI by MDS Task Force criteria: how many and which neuropsychological tests?

Jennifer G Goldman  1 , Samantha Holden, Bichun Ouyang, Bryan Bernard, Christopher G Goetz, Glenn T Stebbins
Affiliations

Diagnosing PD-MCI by MDS Task Force criteria: how many and which neuropsychological tests?

Jennifer G Goldman et al. Mov Disord. 2015 Mar.

Abstract

Background: The optimal properties of a comprehensive (level II) neuropsychological battery for determining Parkinson's disease mild cognitive impairment (PD-MCI) by Movement Disorder Society (MDS) Task Force criteria remain unresolved.

Methods: Seventy-six nondemented PD patients underwent PD-MCI classification using a consensus diagnosis and level II criteria. We examined the optimal number of tests in each of the five designated cognitive domains, identified the best tests within each domain, and determined the best overall battery for PD-MCI level II diagnosis.

Results: A battery with two tests per domain provided a highly practical, robust diagnostic assessment. Level II testing with the two best tests and impairment defined as 2 standard deviations below norms was highly sensitive and specific for PD-MCI diagnosis.

Conclusions: Our findings strongly support the MDS Task Force Level II testing recommendations, provide a framework for creating an optimal, efficient neuropsychological test battery for PD-MCI diagnosis, and offer specific test recommendations.

Keywords: Parkinson's disease; cognitive tests; dementia; mild cognitive impairment.

PubMed Disclaimer

Conflict of interest statement

Relevant conflicts of interest/financial disclosures: none

References

    1. Litvan I, Aarsland D, Adler CH, et al. MDS task force on mild cognitive impairment in Parkinson’s disease: Critical review of PD-MCI. Mov Disord. 2011;26(10):1814–1824. - PMC - PubMed
    1. Pedersen KF, Larsen JP, Tysnes OB, Alves G. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study. JAMA Neurol. 2013;70(5):580–586. - PubMed
    1. Janvin CC, Larsen JP, Aarsland D, Hugdahl K. Subtypes of mild cognitive impairment in Parkinson’s disease: progression to dementia. Mov Disord. 2006;21(9):1343–1349. - PubMed
    1. Litvan I, Goldman JG, Troster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov Disord. 2012;27(3):349–356. - PMC - PubMed
    1. Schinka JA, Loewenstein DA, Raj A, et al. Defining mild cognitive impairment: impact of varying decision criteria on neuropsychological diagnostic frequencies and correlates. Am J Geriatr Psychiatry. 2010;18(8):684–691. - PMC - PubMed

Publication types